Guidance Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.12M Buy
13,420
+485
+4% +$39.1K 0.24% 98
2026
Q1
$1.01M Buy
12,935
+556
+4% +$53.3K 0.23% 107
2025
Q4
$1.25M Buy
12,379
+42
+0.3% +$4.08K 0.31% 75
2025
Q3
$1.16M Buy
12,337
+412
+3% +$37.9K 0.3% 76
2025
Q2
$1.07M Buy
11,925
+243
+2% +$20.6K 0.3% 74
2025
Q1
$991K Buy
11,682
+502
+4% +$44.9K 0.3% 66
2024
Q4
$1.01M Buy
11,180
+92
+0.8% +$7.96K 0.31% 62
2024
Q3
$1.02M Buy
11,088
+95
+0.9% +$7.99K 0.32% 68
2024
Q2
$883K Buy
10,993
+1,070
+11% +$87.7K 0.29% 76
2024
Q1
$796K Buy
9,923
+1,554
+19% +$133K 0.29% 71
2023
Q4
$693K Buy
8,369
+1,215
+17% +$92.6K 0.28% 76
2023
Q3
$548K Buy
7,154
+565
+9% +$47.3K 0.25% 81
2023
Q2
$550K Buy
+6,589
New +$567K 0.24% 84

Other funds holding MDT

Guidance Capital's MDT Position: Q2 2026 in Review

Guidance Capital increased its Medtronic (MDT) stake by 3.7% in Q2 2026, buying an estimated $39.1K and bringing the position to 13,420 shares worth $1.12M. The position accounts for 0.24% of the portfolio, ranked #98.

Guidance Capital first reported a position in MDT in Q2 2023 and has held it in 13 quarters since. The position peaked at $1.25M in Q4 2025. 486 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Guidance Capital held 13,420 shares of Medtronic worth $1.12M as of Q2 2026.
  • Guidance Capital bought 485 Medtronic shares in Q2 2026, an estimated $39.1K.
  • Medtronic made up 0.24% of Guidance Capital's portfolio in Q2 2026, its #98 holding.
  • Guidance Capital first reported a position in Medtronic in Q2 2023 and has held it in 13 quarters since.
  • Guidance Capital's Medtronic position peaked at $1.25M in Q4 2025.
  • 486 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Guidance Capital's 13F filing for Q2 2026, filed 20 Jul 2026.